Pakistan, Oct. 11 -- Sindh Governor Syed Muhammad Nehal Hashmi and Sindh Chief Minister Syed Murad Ali Shah have said that mental health is an essential component of a healthy life. In their separate... Read More
UP Election 2027, Oct. 11 -- Uttar Pradesh Chief Minister Yogi Adityanath has accepted Samajwadi Party (SP) president Akhilesh Yadav's dare to contest the upcoming assembly elections from Ayodhya, inv... Read More
Dhaka, Oct. 11 -- Bangladesh on Sunday strongly and unequivocally condemned Saturday's deadly Houthi attack on King Khalid International Airport in Riyadh that killed 12 people, including two Banglade... Read More
Kathmandu, Oct. 11 -- A landslide that may have blocked a tributary is a possible cause of flash flooding in the Budhi Gandaki river, the Department of Hydrology and Meteorology's Flood Forecasting Se... Read More
Singapore, Oct. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to ... Read More
Singapore, Oct. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Sever... Read More
Singapore, Oct. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutami... Read More
Singapore, Oct. 11 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-0863... Read More
Singapore, Oct. 11 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-blind, Phase 3 Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy Wi... Read More
Singapore, Oct. 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Ver... Read More